Close

Veru Reports Positive Phase 2 Clinical Results of VERU-111 in Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome

Go back to Veru Reports Positive Phase 2 Clinical Results of VERU-111 in Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome

Veru, Inc. (VERU) Trades at High, Up 65%

February 9, 2021 12:14 PM EST

Veru, Inc. (NASDAQ: VERU) Trades at High, Up 65%

... More